nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2C19—Desloratadine—allergic rhinitis	0.0566	0.0761	CbGbCtD
Etoricoxib—PTGS2—Triamcinolone—allergic rhinitis	0.0551	0.0741	CbGbCtD
Etoricoxib—CYP1A2—Desloratadine—allergic rhinitis	0.0522	0.0702	CbGbCtD
Etoricoxib—PTGS2—Betamethasone—allergic rhinitis	0.0473	0.0636	CbGbCtD
Etoricoxib—CYP2C9—Desloratadine—allergic rhinitis	0.0471	0.0633	CbGbCtD
Etoricoxib—CYP2D6—Desloratadine—allergic rhinitis	0.043	0.0579	CbGbCtD
Etoricoxib—CYP2C19—Loratadine—allergic rhinitis	0.0325	0.0437	CbGbCtD
Etoricoxib—CYP2C19—Diphenhydramine—allergic rhinitis	0.0325	0.0437	CbGbCtD
Etoricoxib—CYP1A2—Diphenhydramine—allergic rhinitis	0.03	0.0403	CbGbCtD
Etoricoxib—PTGS2—Dexamethasone—allergic rhinitis	0.0275	0.037	CbGbCtD
Etoricoxib—CYP3A4—Flunisolide—allergic rhinitis	0.0274	0.0368	CbGbCtD
Etoricoxib—CYP2C9—Loratadine—allergic rhinitis	0.027	0.0363	CbGbCtD
Etoricoxib—CYP2C9—Montelukast—allergic rhinitis	0.027	0.0363	CbGbCtD
Etoricoxib—CYP2C9—Diphenhydramine—allergic rhinitis	0.027	0.0363	CbGbCtD
Etoricoxib—CYP3A4—Olopatadine—allergic rhinitis	0.0257	0.0346	CbGbCtD
Etoricoxib—CYP2D6—Loratadine—allergic rhinitis	0.0247	0.0332	CbGbCtD
Etoricoxib—CYP2D6—Diphenhydramine—allergic rhinitis	0.0247	0.0332	CbGbCtD
Etoricoxib—CYP2E1—Dexamethasone—allergic rhinitis	0.0179	0.0241	CbGbCtD
Etoricoxib—CYP3A4—Montelukast—allergic rhinitis	0.0157	0.0211	CbGbCtD
Etoricoxib—CYP3A4—Loratadine—allergic rhinitis	0.0157	0.0211	CbGbCtD
Etoricoxib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0144	0.0193	CbGbCtD
Etoricoxib—CYP2C19—Dexamethasone—allergic rhinitis	0.0112	0.0151	CbGbCtD
Etoricoxib—CYP3A4—Triamcinolone—allergic rhinitis	0.0109	0.0146	CbGbCtD
Etoricoxib—CYP2C9—Dexamethasone—allergic rhinitis	0.00935	0.0126	CbGbCtD
Etoricoxib—CYP3A4—Betamethasone—allergic rhinitis	0.00935	0.0126	CbGbCtD
Etoricoxib—CYP3A4—Prednisolone—allergic rhinitis	0.00922	0.0124	CbGbCtD
Etoricoxib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00874	0.0118	CbGbCtD
Etoricoxib—CYP2D6—Dexamethasone—allergic rhinitis	0.00855	0.0115	CbGbCtD
Etoricoxib—CYP3A4—Dexamethasone—allergic rhinitis	0.00544	0.00731	CbGbCtD
Etoricoxib—MAPK14—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.00134	0.092	CbGpPWpGaD
Etoricoxib—PTGS2—Fluocinonide—Flunisolide—allergic rhinitis	0.00102	0.213	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Flunisolide—allergic rhinitis	0.000614	0.129	CbGdCrCtD
Etoricoxib—MAPK14—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.00059	0.0404	CbGpPWpGaD
Etoricoxib—PTGS2—Fluocinonide—Methylprednisolone—allergic rhinitis	0.000498	0.104	CbGdCrCtD
Etoricoxib—MAPK14—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.000498	0.0341	CbGpPWpGaD
Etoricoxib—PTGS2—Fluocinonide—Dexamethasone—allergic rhinitis	0.00049	0.103	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Betamethasone—allergic rhinitis	0.00049	0.103	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Triamcinolone—allergic rhinitis	0.000479	0.1	CbGdCrCtD
Etoricoxib—MAPK14—Endothelins—CYSLTR1—allergic rhinitis	0.000408	0.0279	CbGpPWpGaD
Etoricoxib—MAPK14—IL4-mediated signaling events—CCL11—allergic rhinitis	0.000399	0.0273	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.000339	0.0232	CbGpPWpGaD
Etoricoxib—MAPK14—Atypical NF-kappaB pathway—NFKB1—allergic rhinitis	0.000317	0.0217	CbGpPWpGaD
Etoricoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	0.0003	0.063	CbGdCrCtD
Etoricoxib—MAPK14—CD40/CD40L signaling—IL4—allergic rhinitis	0.000296	0.0202	CbGpPWpGaD
Etoricoxib—PTGS2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	0.000296	0.062	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Betamethasone—allergic rhinitis	0.000296	0.062	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	0.000289	0.0606	CbGdCrCtD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.000279	0.0191	CbGpPWpGaD
Etoricoxib—MAPK14—IL4-mediated signaling events—IL5—allergic rhinitis	0.000269	0.0184	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.000264	0.0181	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL13—allergic rhinitis	0.000252	0.0172	CbGpPWpGaD
Etoricoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000225	0.0154	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL5—allergic rhinitis	0.000215	0.0147	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000215	0.0147	CbGpPWpGaD
Etoricoxib—MAPK14—IL-4 Signaling Pathway—IL4—allergic rhinitis	0.000214	0.0146	CbGpPWpGaD
Etoricoxib—MAPK14—Estrogen signaling pathway—NFKB1—allergic rhinitis	0.000213	0.0146	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—PFN2—allergic rhinitis	0.000205	0.014	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000204	0.014	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—FOXP3—allergic rhinitis	0.000201	0.0138	CbGpPWpGaD
Etoricoxib—MAPK14—IL4-mediated signaling events—IL10—allergic rhinitis	0.000197	0.0135	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—IL4—allergic rhinitis	0.000197	0.0135	CbGpPWpGaD
Etoricoxib—MAPK14—IL4-mediated signaling events—IL4—allergic rhinitis	0.000192	0.0131	CbGpPWpGaD
Etoricoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.000182	0.0124	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.00018	0.0123	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress—NFKB1—allergic rhinitis	0.000172	0.0118	CbGpPWpGaD
Etoricoxib—MAPK14—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000168	0.0115	CbGpPWpGaD
Etoricoxib—Haemorrhage—Prednisolone—allergic rhinitis	0.000165	0.000699	CcSEcCtD
Etoricoxib—MAPK14—Thromboxane A2 receptor signaling—ICAM1—allergic rhinitis	0.000165	0.0113	CbGpPWpGaD
Etoricoxib—Dizziness—Flunisolide—allergic rhinitis	0.000165	0.000696	CcSEcCtD
Etoricoxib—Conjunctivitis—Triamcinolone—allergic rhinitis	0.000165	0.000696	CcSEcCtD
Etoricoxib—MAPK14—EPO signaling pathway—NFKB1—allergic rhinitis	0.000164	0.0112	CbGpPWpGaD
Etoricoxib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000162	0.000686	CcSEcCtD
Etoricoxib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000161	0.000682	CcSEcCtD
Etoricoxib—Vomiting—Cetirizine—allergic rhinitis	0.000161	0.000681	CcSEcCtD
Etoricoxib—Hallucination—Hydrocortisone—allergic rhinitis	0.000161	0.000679	CcSEcCtD
Etoricoxib—Nausea—Loratadine—allergic rhinitis	0.00016	0.000676	CcSEcCtD
Etoricoxib—Epistaxis—Triamcinolone—allergic rhinitis	0.00016	0.000675	CcSEcCtD
Etoricoxib—Rash—Cetirizine—allergic rhinitis	0.00016	0.000675	CcSEcCtD
Etoricoxib—Dermatitis—Cetirizine—allergic rhinitis	0.00016	0.000674	CcSEcCtD
Etoricoxib—Visual impairment—Prednisolone—allergic rhinitis	0.000159	0.000673	CcSEcCtD
Etoricoxib—Headache—Cetirizine—allergic rhinitis	0.000159	0.000671	CcSEcCtD
Etoricoxib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000159	0.00067	CcSEcCtD
Etoricoxib—Vomiting—Flunisolide—allergic rhinitis	0.000158	0.000669	CcSEcCtD
Etoricoxib—Rash—Flunisolide—allergic rhinitis	0.000157	0.000664	CcSEcCtD
Etoricoxib—Dermatitis—Flunisolide—allergic rhinitis	0.000157	0.000663	CcSEcCtD
Etoricoxib—Weight increased—Betamethasone—allergic rhinitis	0.000157	0.000663	CcSEcCtD
Etoricoxib—Weight increased—Dexamethasone—allergic rhinitis	0.000157	0.000663	CcSEcCtD
Etoricoxib—Hypersensitivity—Montelukast—allergic rhinitis	0.000157	0.000661	CcSEcCtD
Etoricoxib—Headache—Flunisolide—allergic rhinitis	0.000156	0.000659	CcSEcCtD
Etoricoxib—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000155	0.000657	CcSEcCtD
Etoricoxib—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000155	0.000657	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL4—allergic rhinitis	0.000153	0.0105	CbGpPWpGaD
Etoricoxib—Haemoglobin—Triamcinolone—allergic rhinitis	0.000153	0.000646	CcSEcCtD
Etoricoxib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000152	0.000644	CcSEcCtD
Etoricoxib—Asthenia—Montelukast—allergic rhinitis	0.000152	0.000644	CcSEcCtD
Etoricoxib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000152	0.000642	CcSEcCtD
Etoricoxib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000152	0.000641	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.000152	0.00064	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.000152	0.00064	CcSEcCtD
Etoricoxib—Hallucination—Methylprednisolone—allergic rhinitis	0.000151	0.000638	CcSEcCtD
Etoricoxib—Pharyngitis—Triamcinolone—allergic rhinitis	0.000151	0.000638	CcSEcCtD
Etoricoxib—Eye disorder—Hydrocortisone—allergic rhinitis	0.000151	0.000638	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000151	0.000636	CcSEcCtD
Etoricoxib—Myocardial infarction—Betamethasone—allergic rhinitis	0.000151	0.000636	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000151	0.000636	CcSEcCtD
Etoricoxib—Myocardial infarction—Dexamethasone—allergic rhinitis	0.000151	0.000636	CcSEcCtD
Etoricoxib—Nausea—Cetirizine—allergic rhinitis	0.00015	0.000636	CcSEcCtD
Etoricoxib—Pruritus—Montelukast—allergic rhinitis	0.00015	0.000635	CcSEcCtD
Etoricoxib—Conjunctivitis—Dexamethasone—allergic rhinitis	0.000149	0.000631	CcSEcCtD
Etoricoxib—Conjunctivitis—Betamethasone—allergic rhinitis	0.000149	0.000631	CcSEcCtD
Etoricoxib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000149	0.00063	CcSEcCtD
Etoricoxib—MAPK14—CD40/CD40L signaling—NFKB1—allergic rhinitis	0.000149	0.0102	CbGpPWpGaD
Etoricoxib—Nausea—Flunisolide—allergic rhinitis	0.000148	0.000625	CcSEcCtD
Etoricoxib—Arrhythmia—Prednisolone—allergic rhinitis	0.000148	0.000624	CcSEcCtD
Etoricoxib—Visual impairment—Methylprednisolone—allergic rhinitis	0.000146	0.000618	CcSEcCtD
Etoricoxib—Immune system disorder—Hydrocortisone—allergic rhinitis	0.000146	0.000616	CcSEcCtD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.000145	0.00995	CbGpPWpGaD
Etoricoxib—Diarrhoea—Montelukast—allergic rhinitis	0.000145	0.000614	CcSEcCtD
Etoricoxib—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000144	0.000609	CcSEcCtD
Etoricoxib—Erythema—Prednisolone—allergic rhinitis	0.000144	0.000608	CcSEcCtD
Etoricoxib—Eye disorder—Methylprednisolone—allergic rhinitis	0.000142	0.000599	CcSEcCtD
Etoricoxib—Mental disorder—Hydrocortisone—allergic rhinitis	0.000141	0.000598	CcSEcCtD
Etoricoxib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000141	0.000595	CcSEcCtD
Etoricoxib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000141	0.000594	CcSEcCtD
Etoricoxib—Erythema—Hydrocortisone—allergic rhinitis	0.000141	0.000594	CcSEcCtD
Etoricoxib—Dizziness—Montelukast—allergic rhinitis	0.00014	0.000594	CcSEcCtD
Etoricoxib—Haemoglobin—Betamethasone—allergic rhinitis	0.000139	0.000586	CcSEcCtD
Etoricoxib—Haemoglobin—Dexamethasone—allergic rhinitis	0.000139	0.000586	CcSEcCtD
Etoricoxib—Haemorrhage—Dexamethasone—allergic rhinitis	0.000138	0.000583	CcSEcCtD
Etoricoxib—Haemorrhage—Betamethasone—allergic rhinitis	0.000138	0.000583	CcSEcCtD
Etoricoxib—Angiopathy—Methylprednisolone—allergic rhinitis	0.000138	0.000582	CcSEcCtD
Etoricoxib—Hallucination—Dexamethasone—allergic rhinitis	0.000137	0.00058	CcSEcCtD
Etoricoxib—Hallucination—Betamethasone—allergic rhinitis	0.000137	0.00058	CcSEcCtD
Etoricoxib—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000137	0.000579	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000137	0.000578	CcSEcCtD
Etoricoxib—Arrhythmia—Triamcinolone—allergic rhinitis	0.000136	0.000574	CcSEcCtD
Etoricoxib—Vision blurred—Prednisolone—allergic rhinitis	0.000136	0.000573	CcSEcCtD
Etoricoxib—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000136	0.000573	CcSEcCtD
Etoricoxib—Vomiting—Montelukast—allergic rhinitis	0.000135	0.000571	CcSEcCtD
Etoricoxib—Rash—Montelukast—allergic rhinitis	0.000134	0.000566	CcSEcCtD
Etoricoxib—Dermatitis—Montelukast—allergic rhinitis	0.000134	0.000565	CcSEcCtD
Etoricoxib—Headache—Montelukast—allergic rhinitis	0.000133	0.000562	CcSEcCtD
Etoricoxib—Visual impairment—Betamethasone—allergic rhinitis	0.000133	0.000562	CcSEcCtD
Etoricoxib—Visual impairment—Dexamethasone—allergic rhinitis	0.000133	0.000562	CcSEcCtD
Etoricoxib—Mental disorder—Methylprednisolone—allergic rhinitis	0.000133	0.000562	CcSEcCtD
Etoricoxib—Erythema—Triamcinolone—allergic rhinitis	0.000132	0.000559	CcSEcCtD
Etoricoxib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000132	0.000558	CcSEcCtD
Etoricoxib—Erythema—Methylprednisolone—allergic rhinitis	0.000132	0.000558	CcSEcCtD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000132	0.009	CbGpPWpGaD
Etoricoxib—Angioedema—Prednisolone—allergic rhinitis	0.000132	0.000556	CcSEcCtD
Etoricoxib—Dysgeusia—Triamcinolone—allergic rhinitis	0.00013	0.000548	CcSEcCtD
Etoricoxib—Eye disorder—Dexamethasone—allergic rhinitis	0.000129	0.000545	CcSEcCtD
Etoricoxib—Eye disorder—Betamethasone—allergic rhinitis	0.000129	0.000545	CcSEcCtD
Etoricoxib—Angioedema—Hydrocortisone—allergic rhinitis	0.000128	0.000543	CcSEcCtD
Etoricoxib—Nausea—Montelukast—allergic rhinitis	0.000126	0.000533	CcSEcCtD
Etoricoxib—Angiopathy—Dexamethasone—allergic rhinitis	0.000125	0.000529	CcSEcCtD
Etoricoxib—Angiopathy—Betamethasone—allergic rhinitis	0.000125	0.000529	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.000124	0.00851	CbGpPWpGaD
Etoricoxib—Hypertension—Prednisolone—allergic rhinitis	0.000124	0.000525	CcSEcCtD
Etoricoxib—Arrhythmia—Dexamethasone—allergic rhinitis	0.000123	0.000521	CcSEcCtD
Etoricoxib—Arrhythmia—Betamethasone—allergic rhinitis	0.000123	0.000521	CcSEcCtD
Etoricoxib—Alopecia—Dexamethasone—allergic rhinitis	0.000122	0.000515	CcSEcCtD
Etoricoxib—Alopecia—Betamethasone—allergic rhinitis	0.000122	0.000515	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—ICAM1—allergic rhinitis	0.000122	0.00833	CbGpPWpGaD
Etoricoxib—Hypertension—Hydrocortisone—allergic rhinitis	0.000121	0.000513	CcSEcCtD
Etoricoxib—Angioedema—Triamcinolone—allergic rhinitis	0.000121	0.000511	CcSEcCtD
Etoricoxib—Angioedema—Methylprednisolone—allergic rhinitis	0.000121	0.00051	CcSEcCtD
Etoricoxib—MAPK14—TSLP Signaling Pathway—NFKB1—allergic rhinitis	0.00012	0.00823	CbGpPWpGaD
Etoricoxib—MAPK14—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	0.00012	0.00823	CbGpPWpGaD
Etoricoxib—Erythema—Dexamethasone—allergic rhinitis	0.00012	0.000507	CcSEcCtD
Etoricoxib—Erythema—Betamethasone—allergic rhinitis	0.00012	0.000507	CcSEcCtD
Etoricoxib—Anxiety—Hydrocortisone—allergic rhinitis	0.000119	0.000504	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000119	0.000502	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000117	0.000496	CcSEcCtD
Etoricoxib—Oedema—Prednisolone—allergic rhinitis	0.000117	0.000496	CcSEcCtD
Etoricoxib—Shock—Prednisolone—allergic rhinitis	0.000116	0.000488	CcSEcCtD
Etoricoxib—Cough—Triamcinolone—allergic rhinitis	0.000116	0.000488	CcSEcCtD
Etoricoxib—MAPK14—IL12-mediated signaling events—CD4—allergic rhinitis	0.000115	0.00786	CbGpPWpGaD
Etoricoxib—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.000115	0.000485	CcSEcCtD
Etoricoxib—Oedema—Hydrocortisone—allergic rhinitis	0.000115	0.000485	CcSEcCtD
Etoricoxib—MAPK14—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NFKB1—allergic rhinitis	0.000114	0.00783	CbGpPWpGaD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	0.000114	0.00783	CbGpPWpGaD
Etoricoxib—Hypertension—Triamcinolone—allergic rhinitis	0.000114	0.000483	CcSEcCtD
Etoricoxib—Hypertension—Methylprednisolone—allergic rhinitis	0.000114	0.000482	CcSEcCtD
Etoricoxib—Infection—Hydrocortisone—allergic rhinitis	0.000114	0.000482	CcSEcCtD
Etoricoxib—Shock—Hydrocortisone—allergic rhinitis	0.000113	0.000477	CcSEcCtD
Etoricoxib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000113	0.000475	CcSEcCtD
Etoricoxib—Arthralgia—Methylprednisolone—allergic rhinitis	0.000112	0.000475	CcSEcCtD
Etoricoxib—Anxiety—Methylprednisolone—allergic rhinitis	0.000112	0.000473	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000112	0.000472	CcSEcCtD
Etoricoxib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000111	0.000471	CcSEcCtD
Etoricoxib—Dry mouth—Triamcinolone—allergic rhinitis	0.00011	0.000466	CcSEcCtD
Etoricoxib—Angioedema—Dexamethasone—allergic rhinitis	0.00011	0.000464	CcSEcCtD
Etoricoxib—Angioedema—Betamethasone—allergic rhinitis	0.00011	0.000464	CcSEcCtD
Etoricoxib—Anorexia—Hydrocortisone—allergic rhinitis	0.000109	0.000462	CcSEcCtD
Etoricoxib—Confusional state—Methylprednisolone—allergic rhinitis	0.000109	0.000459	CcSEcCtD
Etoricoxib—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.000108	0.000456	CcSEcCtD
Etoricoxib—Oedema—Triamcinolone—allergic rhinitis	0.000108	0.000456	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.000108	0.000455	CcSEcCtD
Etoricoxib—MAPK14—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	0.000108	0.00736	CbGpPWpGaD
Etoricoxib—Infection—Triamcinolone—allergic rhinitis	0.000107	0.000453	CcSEcCtD
Etoricoxib—Infection—Methylprednisolone—allergic rhinitis	0.000107	0.000452	CcSEcCtD
Etoricoxib—Shock—Triamcinolone—allergic rhinitis	0.000106	0.000449	CcSEcCtD
Etoricoxib—Insomnia—Prednisolone—allergic rhinitis	0.000106	0.000449	CcSEcCtD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000106	0.00726	CbGpPWpGaD
Etoricoxib—MAPK14—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.000106	0.00726	CbGpPWpGaD
Etoricoxib—MAPK14—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	0.000106	0.00726	CbGpPWpGaD
Etoricoxib—Shock—Methylprednisolone—allergic rhinitis	0.000106	0.000448	CcSEcCtD
Etoricoxib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000106	0.000447	CcSEcCtD
Etoricoxib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000105	0.000442	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000105	0.000442	CcSEcCtD
Etoricoxib—MAPK14—Innate Immune System—MS4A2—allergic rhinitis	0.000104	0.00711	CbGpPWpGaD
Etoricoxib—Insomnia—Hydrocortisone—allergic rhinitis	0.000104	0.000438	CcSEcCtD
Etoricoxib—Hypertension—Betamethasone—allergic rhinitis	0.000104	0.000438	CcSEcCtD
Etoricoxib—Hypertension—Dexamethasone—allergic rhinitis	0.000104	0.000438	CcSEcCtD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—SMAD3—allergic rhinitis	0.000104	0.00709	CbGpPWpGaD
Etoricoxib—Anxiety—Betamethasone—allergic rhinitis	0.000102	0.000431	CcSEcCtD
Etoricoxib—Anxiety—Dexamethasone—allergic rhinitis	0.000102	0.000431	CcSEcCtD
Etoricoxib—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000101	0.000427	CcSEcCtD
Etoricoxib—Pain—Prednisolone—allergic rhinitis	0.0001	0.000424	CcSEcCtD
Etoricoxib—Decreased appetite—Hydrocortisone—allergic rhinitis	9.97e-05	0.000421	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	9.9e-05	0.000418	CcSEcCtD
Etoricoxib—MAPK14—IL12-mediated signaling events—NFKB1—allergic rhinitis	9.89e-05	0.00677	CbGpPWpGaD
Etoricoxib—Fatigue—Hydrocortisone—allergic rhinitis	9.89e-05	0.000418	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	9.84e-05	0.000416	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	9.82e-05	0.000415	CcSEcCtD
Etoricoxib—Pain—Hydrocortisone—allergic rhinitis	9.81e-05	0.000415	CcSEcCtD
Etoricoxib—Anaphylactic shock—Dexamethasone—allergic rhinitis	9.8e-05	0.000414	CcSEcCtD
Etoricoxib—Oedema—Betamethasone—allergic rhinitis	9.8e-05	0.000414	CcSEcCtD
Etoricoxib—Anaphylactic shock—Betamethasone—allergic rhinitis	9.8e-05	0.000414	CcSEcCtD
Etoricoxib—Oedema—Dexamethasone—allergic rhinitis	9.8e-05	0.000414	CcSEcCtD
Etoricoxib—Insomnia—Triamcinolone—allergic rhinitis	9.77e-05	0.000413	CcSEcCtD
Etoricoxib—Insomnia—Methylprednisolone—allergic rhinitis	9.75e-05	0.000412	CcSEcCtD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	9.75e-05	0.00667	CbGpPWpGaD
Etoricoxib—Infection—Dexamethasone—allergic rhinitis	9.74e-05	0.000411	CcSEcCtD
Etoricoxib—Infection—Betamethasone—allergic rhinitis	9.74e-05	0.000411	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisolone—allergic rhinitis	9.68e-05	0.000409	CcSEcCtD
Etoricoxib—Shock—Betamethasone—allergic rhinitis	9.64e-05	0.000407	CcSEcCtD
Etoricoxib—Shock—Dexamethasone—allergic rhinitis	9.64e-05	0.000407	CcSEcCtD
Etoricoxib—Dyspnoea—Triamcinolone—allergic rhinitis	9.63e-05	0.000407	CcSEcCtD
Etoricoxib—Nervous system disorder—Dexamethasone—allergic rhinitis	9.61e-05	0.000406	CcSEcCtD
Etoricoxib—Nervous system disorder—Betamethasone—allergic rhinitis	9.61e-05	0.000406	CcSEcCtD
Etoricoxib—Thrombocytopenia—Betamethasone—allergic rhinitis	9.6e-05	0.000405	CcSEcCtD
Etoricoxib—Thrombocytopenia—Dexamethasone—allergic rhinitis	9.6e-05	0.000405	CcSEcCtD
Etoricoxib—Dyspepsia—Triamcinolone—allergic rhinitis	9.51e-05	0.000402	CcSEcCtD
Etoricoxib—Dyspepsia—Methylprednisolone—allergic rhinitis	9.49e-05	0.000401	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydrocortisone—allergic rhinitis	9.45e-05	0.000399	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	9.38e-05	0.000396	CcSEcCtD
Etoricoxib—Anorexia—Dexamethasone—allergic rhinitis	9.34e-05	0.000395	CcSEcCtD
Etoricoxib—Anorexia—Betamethasone—allergic rhinitis	9.34e-05	0.000395	CcSEcCtD
Etoricoxib—Urticaria—Prednisolone—allergic rhinitis	9.33e-05	0.000394	CcSEcCtD
Etoricoxib—Fatigue—Triamcinolone—allergic rhinitis	9.31e-05	0.000393	CcSEcCtD
Etoricoxib—Fatigue—Methylprednisolone—allergic rhinitis	9.29e-05	0.000393	CcSEcCtD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	9.28e-05	0.00635	CbGpPWpGaD
Etoricoxib—Pain—Triamcinolone—allergic rhinitis	9.24e-05	0.00039	CcSEcCtD
Etoricoxib—MAPK14—AGE/RAGE pathway—NFKB1—allergic rhinitis	9.17e-05	0.00627	CbGpPWpGaD
Etoricoxib—Urticaria—Hydrocortisone—allergic rhinitis	9.11e-05	0.000385	CcSEcCtD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—TGFB1—allergic rhinitis	9.1e-05	0.00623	CbGpPWpGaD
Etoricoxib—Abdominal pain—Hydrocortisone—allergic rhinitis	9.07e-05	0.000383	CcSEcCtD
Etoricoxib—MAPK14—BCR signaling pathway—NFKB1—allergic rhinitis	9.06e-05	0.0062	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—allergic rhinitis	9.06e-05	0.0062	CbGpPWpGaD
Etoricoxib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	8.93e-05	0.000377	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	8.93e-05	0.000377	CcSEcCtD
Etoricoxib—Feeling abnormal—Triamcinolone—allergic rhinitis	8.9e-05	0.000376	CcSEcCtD
Etoricoxib—Feeling abnormal—Methylprednisolone—allergic rhinitis	8.88e-05	0.000375	CcSEcCtD
Etoricoxib—Insomnia—Betamethasone—allergic rhinitis	8.87e-05	0.000375	CcSEcCtD
Etoricoxib—Insomnia—Dexamethasone—allergic rhinitis	8.87e-05	0.000375	CcSEcCtD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	8.84e-05	0.00604	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	8.81e-05	0.000372	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisolone—allergic rhinitis	8.65e-05	0.000366	CcSEcCtD
Etoricoxib—Dyspepsia—Dexamethasone—allergic rhinitis	8.63e-05	0.000365	CcSEcCtD
Etoricoxib—Dyspepsia—Betamethasone—allergic rhinitis	8.63e-05	0.000365	CcSEcCtD
Etoricoxib—Urticaria—Triamcinolone—allergic rhinitis	8.58e-05	0.000363	CcSEcCtD
Etoricoxib—Urticaria—Methylprednisolone—allergic rhinitis	8.56e-05	0.000362	CcSEcCtD
Etoricoxib—Abdominal pain—Methylprednisolone—allergic rhinitis	8.52e-05	0.00036	CcSEcCtD
Etoricoxib—Decreased appetite—Betamethasone—allergic rhinitis	8.52e-05	0.00036	CcSEcCtD
Etoricoxib—Decreased appetite—Dexamethasone—allergic rhinitis	8.52e-05	0.00036	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	8.46e-05	0.000358	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	8.46e-05	0.000358	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydrocortisone—allergic rhinitis	8.45e-05	0.000357	CcSEcCtD
Etoricoxib—Fatigue—Dexamethasone—allergic rhinitis	8.45e-05	0.000357	CcSEcCtD
Etoricoxib—Fatigue—Betamethasone—allergic rhinitis	8.45e-05	0.000357	CcSEcCtD
Etoricoxib—Pain—Dexamethasone—allergic rhinitis	8.38e-05	0.000354	CcSEcCtD
Etoricoxib—Pain—Betamethasone—allergic rhinitis	8.38e-05	0.000354	CcSEcCtD
Etoricoxib—MAPK14—TCR Signaling Pathway—CD4—allergic rhinitis	8.3e-05	0.00568	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	8.28e-05	0.00566	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—NFKB1—allergic rhinitis	8.28e-05	0.00566	CbGpPWpGaD
Etoricoxib—Asthenia—Hydrocortisone—allergic rhinitis	8.23e-05	0.000348	CcSEcCtD
Etoricoxib—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	8.21e-05	0.00562	CbGpPWpGaD
Etoricoxib—Pruritus—Hydrocortisone—allergic rhinitis	8.12e-05	0.000343	CcSEcCtD
Etoricoxib—Feeling abnormal—Betamethasone—allergic rhinitis	8.08e-05	0.000341	CcSEcCtD
Etoricoxib—Feeling abnormal—Dexamethasone—allergic rhinitis	8.08e-05	0.000341	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	8.02e-05	0.000339	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Betamethasone—allergic rhinitis	8.02e-05	0.000339	CcSEcCtD
Etoricoxib—Hypersensitivity—Triamcinolone—allergic rhinitis	7.96e-05	0.000336	CcSEcCtD
Etoricoxib—Hypersensitivity—Methylprednisolone—allergic rhinitis	7.94e-05	0.000336	CcSEcCtD
Etoricoxib—Diarrhoea—Hydrocortisone—allergic rhinitis	7.85e-05	0.000332	CcSEcCtD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	7.82e-05	0.00535	CbGpPWpGaD
Etoricoxib—Urticaria—Betamethasone—allergic rhinitis	7.79e-05	0.000329	CcSEcCtD
Etoricoxib—Urticaria—Dexamethasone—allergic rhinitis	7.79e-05	0.000329	CcSEcCtD
Etoricoxib—Dizziness—Prednisolone—allergic rhinitis	7.77e-05	0.000328	CcSEcCtD
Etoricoxib—Asthenia—Triamcinolone—allergic rhinitis	7.75e-05	0.000327	CcSEcCtD
Etoricoxib—Abdominal pain—Dexamethasone—allergic rhinitis	7.75e-05	0.000327	CcSEcCtD
Etoricoxib—Abdominal pain—Betamethasone—allergic rhinitis	7.75e-05	0.000327	CcSEcCtD
Etoricoxib—Asthenia—Methylprednisolone—allergic rhinitis	7.73e-05	0.000327	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—NFKB1—allergic rhinitis	7.71e-05	0.00527	CbGpPWpGaD
Etoricoxib—Pruritus—Triamcinolone—allergic rhinitis	7.64e-05	0.000323	CcSEcCtD
Etoricoxib—Pruritus—Methylprednisolone—allergic rhinitis	7.63e-05	0.000322	CcSEcCtD
Etoricoxib—Dizziness—Hydrocortisone—allergic rhinitis	7.59e-05	0.000321	CcSEcCtD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	7.56e-05	0.00517	CbGpPWpGaD
Etoricoxib—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	7.55e-05	0.00517	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	7.49e-05	0.00512	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	7.42e-05	0.00507	CbGpPWpGaD
Etoricoxib—Rash—Prednisolone—allergic rhinitis	7.41e-05	0.000313	CcSEcCtD
Etoricoxib—Dermatitis—Prednisolone—allergic rhinitis	7.4e-05	0.000313	CcSEcCtD
Etoricoxib—Diarrhoea—Methylprednisolone—allergic rhinitis	7.37e-05	0.000312	CcSEcCtD
Etoricoxib—Headache—Prednisolone—allergic rhinitis	7.36e-05	0.000311	CcSEcCtD
Etoricoxib—PTGS2—Selenium Micronutrient Network—ICAM1—allergic rhinitis	7.35e-05	0.00503	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL4—allergic rhinitis	7.32e-05	0.005	CbGpPWpGaD
Etoricoxib—Vomiting—Hydrocortisone—allergic rhinitis	7.29e-05	0.000308	CcSEcCtD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	7.28e-05	0.00498	CbGpPWpGaD
Etoricoxib—Rash—Hydrocortisone—allergic rhinitis	7.23e-05	0.000306	CcSEcCtD
Etoricoxib—Dermatitis—Hydrocortisone—allergic rhinitis	7.23e-05	0.000305	CcSEcCtD
Etoricoxib—Headache—Hydrocortisone—allergic rhinitis	7.19e-05	0.000304	CcSEcCtD
Etoricoxib—MAPK14—TCR Signaling Pathway—NFKB1—allergic rhinitis	7.15e-05	0.00489	CbGpPWpGaD
Etoricoxib—Dizziness—Triamcinolone—allergic rhinitis	7.14e-05	0.000302	CcSEcCtD
Etoricoxib—Dizziness—Methylprednisolone—allergic rhinitis	7.13e-05	0.000301	CcSEcCtD
Etoricoxib—Asthenia—Betamethasone—allergic rhinitis	7.03e-05	0.000297	CcSEcCtD
Etoricoxib—Asthenia—Dexamethasone—allergic rhinitis	7.03e-05	0.000297	CcSEcCtD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	7.03e-05	0.00481	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	7.03e-05	0.00481	CbGpPWpGaD
Etoricoxib—Nausea—Prednisolone—allergic rhinitis	6.98e-05	0.000295	CcSEcCtD
Etoricoxib—Pruritus—Dexamethasone—allergic rhinitis	6.93e-05	0.000293	CcSEcCtD
Etoricoxib—Pruritus—Betamethasone—allergic rhinitis	6.93e-05	0.000293	CcSEcCtD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	6.91e-05	0.00473	CbGpPWpGaD
Etoricoxib—Vomiting—Triamcinolone—allergic rhinitis	6.87e-05	0.00029	CcSEcCtD
Etoricoxib—Vomiting—Methylprednisolone—allergic rhinitis	6.85e-05	0.00029	CcSEcCtD
Etoricoxib—Nausea—Hydrocortisone—allergic rhinitis	6.81e-05	0.000288	CcSEcCtD
Etoricoxib—Rash—Triamcinolone—allergic rhinitis	6.81e-05	0.000288	CcSEcCtD
Etoricoxib—Dermatitis—Triamcinolone—allergic rhinitis	6.8e-05	0.000288	CcSEcCtD
Etoricoxib—Rash—Methylprednisolone—allergic rhinitis	6.8e-05	0.000287	CcSEcCtD
Etoricoxib—Dermatitis—Methylprednisolone—allergic rhinitis	6.79e-05	0.000287	CcSEcCtD
Etoricoxib—Headache—Triamcinolone—allergic rhinitis	6.77e-05	0.000286	CcSEcCtD
Etoricoxib—Headache—Methylprednisolone—allergic rhinitis	6.75e-05	0.000285	CcSEcCtD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	6.74e-05	0.00461	CbGpPWpGaD
Etoricoxib—Diarrhoea—Dexamethasone—allergic rhinitis	6.71e-05	0.000283	CcSEcCtD
Etoricoxib—Diarrhoea—Betamethasone—allergic rhinitis	6.71e-05	0.000283	CcSEcCtD
Etoricoxib—MAPK14—MyD88-independent cascade—NFKB1—allergic rhinitis	6.63e-05	0.00453	CbGpPWpGaD
Etoricoxib—Dizziness—Betamethasone—allergic rhinitis	6.48e-05	0.000274	CcSEcCtD
Etoricoxib—Dizziness—Dexamethasone—allergic rhinitis	6.48e-05	0.000274	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	6.47e-05	0.00443	CbGpPWpGaD
Etoricoxib—Nausea—Triamcinolone—allergic rhinitis	6.42e-05	0.000271	CcSEcCtD
Etoricoxib—Nausea—Methylprednisolone—allergic rhinitis	6.4e-05	0.00027	CcSEcCtD
Etoricoxib—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	6.4e-05	0.00438	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	6.3e-05	0.00431	CbGpPWpGaD
Etoricoxib—Vomiting—Betamethasone—allergic rhinitis	6.23e-05	0.000263	CcSEcCtD
Etoricoxib—Vomiting—Dexamethasone—allergic rhinitis	6.23e-05	0.000263	CcSEcCtD
Etoricoxib—Rash—Dexamethasone—allergic rhinitis	6.18e-05	0.000261	CcSEcCtD
Etoricoxib—Rash—Betamethasone—allergic rhinitis	6.18e-05	0.000261	CcSEcCtD
Etoricoxib—Dermatitis—Betamethasone—allergic rhinitis	6.17e-05	0.000261	CcSEcCtD
Etoricoxib—Dermatitis—Dexamethasone—allergic rhinitis	6.17e-05	0.000261	CcSEcCtD
Etoricoxib—Headache—Betamethasone—allergic rhinitis	6.14e-05	0.000259	CcSEcCtD
Etoricoxib—Headache—Dexamethasone—allergic rhinitis	6.14e-05	0.000259	CcSEcCtD
Etoricoxib—MAPK14—Immune System—MS4A2—allergic rhinitis	6.05e-05	0.00414	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—NFKB1—allergic rhinitis	5.96e-05	0.00408	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—TGFB1—allergic rhinitis	5.96e-05	0.00408	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	5.85e-05	0.00401	CbGpPWpGaD
Etoricoxib—Nausea—Betamethasone—allergic rhinitis	5.82e-05	0.000246	CcSEcCtD
Etoricoxib—Nausea—Dexamethasone—allergic rhinitis	5.82e-05	0.000246	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—ICAM1—allergic rhinitis	5.81e-05	0.00398	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	5.61e-05	0.00384	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CD4—allergic rhinitis	5.6e-05	0.00383	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	5.27e-05	0.0036	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	5.05e-05	0.00346	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL5—allergic rhinitis	5.02e-05	0.00344	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	4.99e-05	0.00342	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—ADIPOQ—allergic rhinitis	4.96e-05	0.00339	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—NFKB1—allergic rhinitis	4.91e-05	0.00336	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—NFKB1—allergic rhinitis	4.65e-05	0.00318	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	4.42e-05	0.00303	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	4.39e-05	0.003	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—NFKB1—allergic rhinitis	4.34e-05	0.00297	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—NFKB1—allergic rhinitis	4e-05	0.00274	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.92e-05	0.00268	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	3.69e-05	0.00252	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFB1—allergic rhinitis	3.62e-05	0.00247	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—SMAD3—allergic rhinitis	3.6e-05	0.00247	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTGDR2—allergic rhinitis	3.33e-05	0.00228	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-G—allergic rhinitis	3.27e-05	0.00224	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.26e-05	0.00223	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TGFB1—allergic rhinitis	3.06e-05	0.0021	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—NFKB1—allergic rhinitis	3.02e-05	0.00207	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.9e-05	0.00199	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—NFKB1—allergic rhinitis	2.84e-05	0.00194	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL5—allergic rhinitis	2.63e-05	0.0018	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CYSLTR1—allergic rhinitis	2.61e-05	0.00179	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL11—allergic rhinitis	2.52e-05	0.00172	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.5e-05	0.00171	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.09e-05	0.00143	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQB1—allergic rhinitis	2.04e-05	0.0014	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—allergic rhinitis	1.88e-05	0.00128	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—SMAD3—allergic rhinitis	1.84e-05	0.00126	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NFKB1—allergic rhinitis	1.83e-05	0.00125	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TAC1—allergic rhinitis	1.83e-05	0.00125	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL5—allergic rhinitis	1.7e-05	0.00116	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NFKB1—allergic rhinitis	1.62e-05	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—allergic rhinitis	1.53e-05	0.00104	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—allergic rhinitis	1.5e-05	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ICAM1—allergic rhinitis	1.49e-05	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SMAD3—allergic rhinitis	1.2e-05	0.00082	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—allergic rhinitis	1.09e-05	0.000748	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SMAD3—allergic rhinitis	1.09e-05	0.000748	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NFKB1—allergic rhinitis	9.42e-06	0.000645	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—allergic rhinitis	6.45e-06	0.000441	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFKB1—allergic rhinitis	6.09e-06	0.000417	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—allergic rhinitis	5.08e-06	0.000347	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—allergic rhinitis	4.63e-06	0.000317	CbGpPWpGaD
